Continuing Care for Justice-involved Individuals

NCT07593274 | Completed

• 2 other identifiers: FRIEND SRESEARCH_01UG3DA058305-01
• Study Type: interventional
• Target: 31
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this open label feasibility trial is to determine the feasibility of using a mobile continuing care app to augment community treatment for individuals under justice supervision receiving community substance use disorder treatment.

Conditions

Substance Use Disorder (SUD)

Keywords

substance use disorder; justice involved; community treatment

Outcome Measures

Primary Outcomes (2)

• app usability

  Questions about usability will be asked using the System Usability Scale (SUS), one of the most widely used standardized measures to assess technology usability. Using this scale, participants are asked to provide a score for 10-items, using 5-point Likert scales, regarding: a) ease of use, and b) learnability.

  12 weeks post baseline

• Feasibility and Satisfaction Survey

  Feasibility and Satisfaction Survey (FSS) that was developed and used in our prior research and will be used to assesses feasibility and satisfaction. Questions will consist of 5-point Likert scales and open-ended questions focused on: 1) program utilization \[frequency of reviewing app content\], 2) overall look, feel, and experience, 3) ease of use, and 4) app content/tools (i.e., relevance, usefulness, and engagement).

  12-weeks post-baseline

Study Arms (1)

continuing care app

EXPERIMENTAL

continuing care app through a mobile cell phone

Device: continuing care app

Interventions

continuing care app DEVICE

continuing care app is an app on a smartphone

continuing care app

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• \) age 18 or older, 2) currently on probation or parole, 3) currently a client receiving outpatient substance use treatment at one of the three participating clinics, 4) willing to receive supplemental treatment services through a mobile app, and 5) willing to provide informed consent and complete research assessments

You may not qualify if:

• \) Active medical history that may preclude participation (e.g., requires higher level of care; active psychosis; compromised comprehension)

Sponsors & Collaborators

• Friends Research Institute, Inc.: lead

Study Sites (1)

Friends Research Institute

Baltimore, Maryland, 21201-5633, United States

Location

MeSH Terms

Conditions

Substance-Related Disorders

Condition Hierarchy (Ancestors)

Chemically-Induced Disorders; Mental Disorders

Study Officials

• Michael S Gordon, DPA

  Friends Research Institute, Inc.

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NON RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Model Details: continuing care app

Study Record Dates

• First Submitted: May 12, 2026
• First Posted: May 18, 2026
• Study Start: May 8, 2025
• Primary Completion: December 1, 2025
• Study Completion: December 31, 2025
• Last Updated: May 18, 2026

Record last verified: 2025-01

Locations

US (1)